Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ANGO
HOLDAngioDynamics, Inc. · Healthcare · United States · $554M · Avg Vol: $7M/d
COMPANY DESCRIPTION
AngioDynamics, Inc. designs, manufactures, and sells innovative medical devices for minimally invasive diagnosis and treatment across areas like peripheral vascular disease and oncology. Its competitive moat is built upon proprietary technologies such as the NanoKnife for irreversible electroporation and the AngioVac for vascular thrombus management, serving critical unmet medical needs. The company maintains strong relationships within the medical community, continuously innovating in its specialized therapeutic segments.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 316.2M | 338.8M | 303.9M | 292.5M | -2.6% | 313.7M | 314.0M | 329.6M | 6.2% |
| EPS | — | -0.68 | -1.33 | -4.59 | -0.83 | — | -0.77 | — | — | — |
| Shares | — | 39.2M | 39.6M | 40.4M | 41.0M | +4.7% | 41.3M | — | — | — |
| Debt | 20.0M | 33.8M | 64.6M | 4.7M | — | -38.2% | 11.4M | — | — | — |
| Equity | — | 424.5M | 378.3M | 205.6M | 183.0M | -24.5% | — | — | — | — |
| Op CF | — | -7.2M | 78.0K | -28.2M | -10.1M | — | 4.4M | — | — | — |
| Inv CF | — | -19.3M | -9.7M | 123.7M | -10.2M | — | — | — | — | — |
| Fin CF | — | 7.7M | 25.4M | -64.2M | -0.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ANGO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ANGO | AngioDynamics, Inc.(you) | $554M | 63 | HOLD |
| BLFS | BioLife Solutions, Inc. | $1.4B | 57 | HOLD |
| SMTI | Sanara MedTech Inc. | $219M | 57 | HOLD |
| STAA | STAAR Surgical Company | $1.5B | 57 | HOLD |
| ATRC | AtriCure, Inc. | $1.5B | 58 | HOLD |
| OSUR | OraSure Technologies, Inc. | $307M | 48 | HOLD |
| EMBC | Embecta Corp. | $207M | 73 | BUY |
| AZTA | Azenta, Inc. | $1.2B | 42 | HOLD |
| LMAT | LeMaitre Vascular, Inc. | $2.2B | 76 | BUY |
| XRAY | DENTSPLY SIRONA Inc. | $2.2B | 77 | BUY |
Peer medians: ROE -21.7% · P/E 27.3x · Gross margin 48.9%